InvestorsHub Logo
Followers 2
Posts 505
Boards Moderated 0
Alias Born 02/23/2019

Re: None

Wednesday, 06/05/2019 6:45:58 PM

Wednesday, June 05, 2019 6:45:58 PM

Post# of 9239
Exciting to be a CRON holder.

“Merrill Lynch argues that the reason to buy is that the Cronos we see today will hardly be recognizable by the time tomorrow (figuratively speaking) rolls around.

Cronos' alliance with Altria, combined with its ability to "flex" the $1.8 billion in cash on its balance sheet to expand production and make new deals to grow its influence, are the start of a "transformation" that will result in "a vastly different co. in the years ahead," says Merrill Lynch.

Moreover, currently, Cronos is an almost entirely domestic Canadian company. However, the analyst believes that it's close to announcing a launch of cannabidiol (CBD) products for sale in the U.S. as well, the success of which will yield "improving near-term visibility in the largest market for cannabis derived compounds in the world."

This will be a "significant catalyst" for Cronos stock, predicts the analyst. "As this process accelerates," Merrill Lynch says, arguments against the company based on its high valuation, low production volumes, or both, may become "increasingly untenable."

https://finance.yahoo.com/news/just-cronos-group-stock-upgraded-192006947.html?.tsrc=applewf
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRON News